Table 3.
Feline panleukopenia pre-vaccination antibody titre on day 0 and number of cats with an at least ⩾four-fold titre increase during the course of the study
| Number of cats with a ⩾four-fold antibody titre increase with the respective pre-vaccination antibody titre on day 0 | ||
|---|---|---|
| Pre-vaccination FPV antibody titre on day 0 | Retrovirus-infected cats | Non-infected cats |
| <1:10 | 0/0 (0) | 7/8 (87.5) |
| 1:10 | 0/0 (0) | 2/2 (100) |
| 1:20 | 0/0 (0) | 3/5 (60.0) |
| 1:40 | 0/0 (0) | 3/4 (75.0) |
| 1:80 | 0/0 (0) | 3/6 (50.0) |
| 1:160 | 0/0 (0) | 1/7 (14.3) |
| 1:320 | 1/3 (33.3) | 1/8 (12.5) |
| 1:640 | 0/4 (0) | 1/8 (12.5) |
| 1:1280 | 0/1 (0) | 1/10 (10.0) |
| 1:2560 | 0/0 (0) | 0/8 (0) |
| 1:5120 | 0/0 (0) | 0/0 (0) |
| 1:10240 | 0/0 (0) | 0/1 (0) |
| Total number of cats with ⩾four-fold antibody titre increase | 1/8 (12.5) | 22/67 (32.8) |
Data are n (%)
FPV = feline panleukopenia virus